Abraxis BioScience
Biotechnology ResearchCalifornia, United States51-200 Employees
Abraxis BioScience is a biotechnology company focused on developing and delivering therapeutics for cancer and other critical illnesses. Its lead product, ABRAXANE, exemplifies its approach to treating cancer by employing a nanoparticle-based, protein-bound formulation that supports delivery of paclitaxel to tumor sites. The company positions itself as a fully integrated entity spanning discovery through commercialization, with a pipeline centered on biologically interactive delivery systems derived from the natural properties of albumin. Based in Los Angeles, California, Abraxis operates within the biotechnology research sector and targets clinicians and patients seeking more effective and safer cancer treatments. A notable development in its recent activity includes collaboration and licensing arrangements with ProMetic Life Sciences, reflecting its strategy to expand its portfolio and therapeutic reach beyond its initial offerings.
1-888-653-2347 
support@leadiq.com 
